Abcepta is a global biotechnology company based in San Diego, California, with offices around the world. Abcepta is a leading manufacturer of primary antibodies with more than a decade of experience. Meeting the ever changing demands of research and drug discovery through a thoughtful target selection process and strengthened validation-standards.
In addition, Abcepta offers the highest quality services including custom antibody development, custom peptide synthesis and custom protein expression. Synthesis of difficult peptides, including long peptides, is a core competency of Abcepta. High quality, rapid turnaround and personal support for all Abcepta services are guaranteed.